{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:34:44Z","timestamp":1787668484389,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01DE028172"],"award-info":[{"award-number":["R01DE028172"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03CA223886"],"award-info":[{"award-number":["R03CA223886"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA226981"],"award-info":[{"award-number":["R01CA226981"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03CA231766"],"award-info":[{"award-number":["R03CA231766"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0315"],"award-info":[{"award-number":["W81XWH-20-1-0315"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-PCRP-IDA"],"award-info":[{"award-number":["W81XWH-20-PCRP-IDA"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2110433"],"award-info":[{"award-number":["W81XWH2110433"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-PCRP - IDA ( W81XWH2110433"],"award-info":[{"award-number":["W81XWH-20-PCRP - IDA ( W81XWH2110433"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.canlet.2024.216713","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:50:16Z","timestamp":1707886216000},"page":"216713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Interplay between B7\u2013H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"587","author":[{"given":"Giulia","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-7009","authenticated-orcid":false,"given":"Marco","family":"Ventin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7011-4017","authenticated-orcid":false,"given":"Filippos","family":"Kontos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4047-0926","authenticated-orcid":false,"given":"Theodoros","family":"Michelakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Sekigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6078-9766","authenticated-orcid":false,"given":"Vincenzo","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sabbatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananthan","family":"Sadagopan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-7539","authenticated-orcid":false,"given":"Paul A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Bardeesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soldano","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canlet.2024.216713_bib1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00262-018-2131-2","article-title":"Defective HLA class I antigen processing machinery in cancer","volume":"67","author":"Cai","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"12","key":"10.1016\/j.canlet.2024.216713_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.trecan.2021.07.006","article-title":"HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy","volume":"7","author":"Maggs","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2024.216713_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-4939-9773-2_15","article-title":"HLA class I antigen processing machinery defects in cancer cells-frequency, functional significance, and clinical relevance with special emphasis on their role in T cell-based immunotherapy of malignant disease","volume":"2055","author":"Seliger","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.canlet.2024.216713_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnci\/djaa073","article-title":"Tumor microenvironment immune response in pancreatic ductal adenocarcinoma patients treated with neoadjuvant therapy","volume":"113","author":"Michelakos","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.canlet.2024.216713_bib5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-20-2584","article-title":"B7-H3: an attractive target for antibody-based immunotherapy","volume":"27","author":"Kontos","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.216713_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14712598.2021.1862791","article-title":"B7-H3 targeted antibody-based immunotherapy of malignant diseases","volume":"21","author":"Michelakos","year":"2021","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"10.1016\/j.canlet.2024.216713_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1158\/1078-0432.CCR-15-0715","article-title":"PD-L1 and HLA class I antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma","volume":"22","author":"Sabbatino","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216713_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1193963","article-title":"B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers","volume":"13","author":"Ventin","year":"2023","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2024.216713_bib9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2024.216713_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0022-1759(93)90300-V","article-title":"Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues","volume":"161","author":"Temponi","year":"1993","journal-title":"J. Immunol. Methods"},{"issue":"7","key":"10.1016\/j.canlet.2024.216713_bib11","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.4049\/jimmunol.137.7.2299","article-title":"Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products","volume":"137","author":"Stam","year":"1986","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2024.216713_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0161-5890(98)00026-1","article-title":"Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents","volume":"35","author":"Sernee","year":"1998","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2024.216713_bib13","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4049\/jimmunol.171.4.1918","article-title":"Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide","volume":"171","author":"Perosa","year":"2003","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2024.216713_bib14","first-page":"761","article-title":"A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells","volume":"68","author":"Imai","year":"1982","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.canlet.2024.216713_bib15","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.4049\/jimmunol.165.6.3275","article-title":"Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains","volume":"165","author":"Desai","year":"2000","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.canlet.2024.216713_bib16","first-page":"4043","article-title":"Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients","volume":"9","author":"Ogino","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216713_bib17","first-page":"445","article-title":"HLA and cancer: 12th international histocompatibility workshop study","volume":"31","author":"Garrido","year":"1997","journal-title":"ChemInform"},{"issue":"8","key":"10.1016\/j.canlet.2024.216713_bib18","first-page":"716","article-title":"Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies","volume":"109","author":"McCarty","year":"1985","journal-title":"Arch. Pathol. Lab Med."},{"issue":"5","key":"10.1016\/j.canlet.2024.216713_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"269","key":"10.1016\/j.canlet.2024.216713_bib20","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"W1","key":"10.1016\/j.canlet.2024.216713_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.canlet.2024.216713_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"D1","key":"10.1016\/j.canlet.2024.216713_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky1094","article-title":"Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis","volume":"47","author":"Zheng","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.canlet.2024.216713_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw983","article-title":"Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse","volume":"45","author":"Mei","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.canlet.2024.216713_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Contr. Clin. Trials"},{"key":"10.1016\/j.canlet.2024.216713_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.molimm.2017.12.005","article-title":"The regulatory network behind MHC class I expression","volume":"113","author":"Jongsma","year":"2019","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2024.216713_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00251-019-01106-z","article-title":"Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance","volume":"71","author":"Vijayan","year":"2019","journal-title":"Immunogenetics"},{"issue":"52","key":"10.1016\/j.canlet.2024.216713_bib28","doi-asserted-by":"crossref","first-page":"26835","DOI":"10.1073\/pnas.1914915116","article-title":"Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma","volume":"116","author":"Porter","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.canlet.2024.216713_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41419-020-2252-3","article-title":"B7-H3 promotes colorectal cancer angiogenesis through activating the NF-\u03baB pathway to induce VEGFA expression","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216713_bib30","article-title":"Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4\/NF-\u03baB pathway","volume":"6","author":"Xie","year":"2016","journal-title":"Sci. Rep."},{"issue":"13_Supplement","key":"10.1016\/j.canlet.2024.216713_bib31","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1158\/1538-7445.AM2018-5461","article-title":"Abstract 5461: B7-H3 regulates NF-kB signaling in cancer cells by modulating the degradation and re-synthesis of IkB\u03b1","volume":"78","author":"Glazer","year":"2018","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.canlet.2024.216713_bib32","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1158\/1078-0432.CCR-20-2487","article-title":"A pan-histone deacetylase inhibitor enhances the antitumor activity of B7-H3-specific CAR T cells in solid tumors","volume":"27","author":"Lei","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2024.216713_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1535-7163.MCT-20-0446","article-title":"Targeting radiation-resistant prostate cancer stem cells by B7-H3 CAR T cells","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.canlet.2024.216713_bib34","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3389\/fonc.2020.01527","article-title":"MEK inhibitor augments antitumor activity of B7-H3-redirected bispecific antibody","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.216713_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12967-023-03875-4","article-title":"A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.canlet.2024.216713_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084109","article-title":"Immune checkpoints, inhibitors and radionuclides in prostate cancer: promising combinatorial therapy approach","volume":"22","author":"Kgatle","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.canlet.2024.216713_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061436","article-title":"Emerging canonical and non-canonical roles of granzyme B in Health and disease","volume":"14","author":"Tibbs","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.canlet.2024.216713_bib38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/cr.2017.90","article-title":"Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function","volume":"27","author":"Lee","year":"2017","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.canlet.2024.216713_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.03.005","article-title":"Eradication of tumors through simultaneous ablation of CD276\/B7-H3-positive tumor cells and tumor vasculature","volume":"31","author":"Seaman","year":"2017","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.canlet.2024.216713_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41423-019-0305-2","article-title":"Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy","volume":"17","author":"Cai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2024.216713_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000505756","article-title":"B7-H3 and B7-H4 expression in breast cancer and their association with clinicopathological variables and T cell infiltration","volume":"87","author":"Kim","year":"2020","journal-title":"Pathobiology"},{"issue":"2","key":"10.1016\/j.canlet.2024.216713_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lungcan.2006.05.012","article-title":"B7-H3 and B7-H4 expression in non-small-cell lung cancer","volume":"53","author":"Sun","year":"2006","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2024.216713_bib43","first-page":"2646","article-title":"B7-H3 expression associates with tumor invasion and patient's poor survival in human esophageal cancer","volume":"7","author":"Chen","year":"2015","journal-title":"Am J Transl Res"},{"issue":"8","key":"10.1016\/j.canlet.2024.216713_bib44","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00262-010-0841-1","article-title":"Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma","volume":"59","author":"Sun","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.canlet.2024.216713_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2011.09.012","article-title":"Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis","volume":"124","author":"Brunner","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2024.216713_bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/PGP.0000000000000116","article-title":"Epithelial and tumor-associated endothelial expression of B7-H3 in cervical carcinoma: relation with CD8+ intraepithelial lymphocytes, FIGO stage, and phosphohistone H3 (PHH3) reactivity","volume":"34","author":"Brustmann","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"8","key":"10.1016\/j.canlet.2024.216713_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002455","article-title":"B7 score and T cell infiltration stratify immune status in prostate cancer","volume":"9","author":"Zhou","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2024.216713_bib48","article-title":"Overexpression of B7-H3 is associated with poor prognosis in laryngeal cancer","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.216713_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12885-022-09294-w","article-title":"Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer","volume":"22","author":"Si","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2024.216713_bib50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejca.2020.03.033","article-title":"Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer","volume":"133","author":"Yim","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2024.216713_bib51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2567.2009.03236.x","article-title":"Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites","volume":"130","author":"Kobori","year":"2010","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.canlet.2024.216713_bib52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/85339","article-title":"B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production","volume":"2","author":"Chapoval","year":"2001","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.canlet.2024.216713_bib53","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.4049\/jimmunol.168.12.6294","article-title":"Characterization of mouse and human B7-H3 genes","volume":"168","author":"Sun","year":"2002","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2024.216713_bib54","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.4049\/jimmunol.173.4.2500","article-title":"Murine B7-H3 is a negative regulator of T cells","volume":"173","author":"Prasad","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2024.216713_bib55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0888-7543(03)00126-5","article-title":"Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss","volume":"82","author":"Ling","year":"2003","journal-title":"Genomics"},{"key":"10.1016\/j.canlet.2024.216713_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.598001","article-title":"High TIL, HLA, and immune checkpoint expression in conventional high-grade and dedifferentiated chondrosarcoma and poor clinical course of the disease","volume":"11","author":"Nota","year":"2021","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2024.216713_bib57","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/jclinpath-2017-204387","article-title":"Immunohistochemistry on old archival paraffin blocks: is there an expiry date?","volume":"70","author":"Grillo","year":"2017","journal-title":"J. Clin. Pathol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:05:22Z","timestamp":1777550722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352400106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":57,"alternative-id":["S030438352400106X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216713","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay between B7\u2013H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216713"}}